Please login to the form below

Not currently logged in
Email:
Password:

Celgene engages IBM Watson for patient safety work

Aims to improve its pharmacovigilance methods with a new cloud-based platform
Celgene

Celgene has teamed up with IBM Watson Health to improve its existing pharmacovigilance methods through the creation of a new cloud-based drug evaluation platform.

Built using the Watson Health Cloud supercomputer, the new system will collect patient data to assess, monitor and report adverse drug reactions.

IBM says the high volumes of data will be obtained from “diverse sources, including anonymised electronic medical records, medical claims databases and other healthcare information sources”.

'Watson for Patient Safety' aims to aid life sciences companies in managing and interpreting Individual Case Safety Reports (ICSRs), using its trademark cognitive computing technology to increasingly identify potential drug safety signals.

The partners hope this will reduce the time and monetary drain of failed late-stage clinical trials for drug developers through access to such comprehensive outcome- and evidence-based profiling, ultimately getting drugs to market faster.

John Freeman, Celgene's corporate vice president of global drug safety and risk management, said: “With this collaboration, we intend to create a paradigm shift in identifying patient safety data that we hope can be applied across the entire product lifecycle - from early development to approved medicines.

“The new offering we are co-developing will bring the cognitive computing power of Watson and its growing view of clinical, research and social health data to bear on this critical healthcare challenge.”

Due to be developed across several phases, the first module of 'Watson for Patient Safety' is expected to be ready within the next year.

Article by
Rebecca Clifford

3rd November 2016

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Frontera

We live in a time of participation – patients actively involved in their own care recover faster and live longer....

Latest intelligence

NEW EU DATA PROTECTION REGULATION POISED TO CHANGE DATA PRIVACY LANDSCAPE
NEW EU DATA PROTECTION REGULATION POISED TO CHANGE DATA PRIVACY LANDSCAPE The bold digital clock featured on the EUGDPR (EU General Data Protection Regulation)1 website indicates – to the second...
Health knowledge: Why is it so important?
Health knowledge plays an important role in population health, but by itself is rarely enough to prompt a change in the behaviours that cause the risks....
Personas: a top tool for personalising pharma marketing campaigns
Healthcare customers are calling for greater personalisation in care from providers. Here, we explain why personas are the top tool for ensuring your brand meets this need efficiently and effectively....

Infographics